Kofflag-LS Oral Drops is a combination medication containing Levosalbutamol (0.25 mg), Ambroxol (7.5 mg), and Guaifenesin (12.5 mg) designed for the symptomatic relief of respiratory conditions associated with bronchospasm and excessive mucus production. Levosalbutamol, a selective β2-adrenergic receptor agonist, acts as a bronchodilator by relaxing the smooth muscles of the airways, thereby improving airflow and alleviating bronchoconstriction. Ambroxol serves as a mucolytic agent, facilitating the breakdown and clearance of viscous mucus from the respiratory tract, which enhances expectoration and reduces cough severity. Guaifenesin functions as an expectorant, promoting the hydration of respiratory secretions and aiding in the loosening and expulsion of mucus. This synergistic combination is particularly effective in managing conditions such as acute and chronic bronchitis, asthma exacerbations, and other obstructive airway diseases where cough and mucus retention are prominent symptoms. Kofflag-LS Oral Drops should be administered as per the prescribed dosage and under medical supervision to ensure safety and efficacy. Caution is advised in patients with hypersensitivity to any component, cardiovascular disorders, or hyperthyroidism. The formulation is intended for oral use and should be stored at room temperature, away from direct sunlight and moisture.